Celecoxib or metformin in combination with other drugs reduces the phosphorylation level of mTOR by inactivating the PI3K/Akt/mTOR or AMPK/mTOR signaling pathways, resulting in tumor inhibition 59-61. Here, AKT1 is linked to neoplasm.